These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses. Tokars JI, Lewis P, DeStefano F, Wise M, Viray M, Morgan O, Gargiullo P, Vellozzi C. Pharmacoepidemiol Drug Saf; 2012 May; 21(5):546-52. PubMed ID: 22407672 [Abstract] [Full Text] [Related]
3. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010. Polakowski LL, Sandhu SK, Martin DB, Ball R, Macurdy TE, Franks RL, Gibbs JM, Kropp GF, Avagyan A, Kelman JA, Worrall CM, Sun G, Kliman RE, Burwen DR. Am J Epidemiol; 2013 Sep 15; 178(6):962-73. PubMed ID: 23652165 [Abstract] [Full Text] [Related]
4. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, Vellozzi C, Yih WK, Gellin B, Lurie N, H1N1 GBS Meta-Analysis Working Group. Lancet; 2013 Apr 27; 381(9876):1461-8. PubMed ID: 23498095 [Abstract] [Full Text] [Related]
5. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2009 Dec 11; 58(48):1351-6. PubMed ID: 20010511 [Abstract] [Full Text] [Related]
6. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009). Souayah N, Yacoub HA, Khan HM, Michas-Martin PA, Menkes DL, Maybodi L, Qureshi AI. Neuroepidemiology; 2012 Dec 11; 38(4):227-32. PubMed ID: 22555646 [Abstract] [Full Text] [Related]
8. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Grimaldi-Bensouda L, Alpérovitch A, Besson G, Vial C, Cuisset JM, Papeix C, Lyon-Caen O, Benichou J, Rossignol M, Lucien Abenhaim for the GBS-PGRx Study Group. Am J Epidemiol; 2011 Aug 01; 174(3):326-35. PubMed ID: 21652600 [Abstract] [Full Text] [Related]
9. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2009 Nov 13; 58(44):1241-5. PubMed ID: 19910912 [Abstract] [Full Text] [Related]
10. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010. Yih WK, Lee GM, Lieu TA, Ball R, Kulldorff M, Rett M, Wahl PM, McMahill-Walraven CN, Platt R, Salmon DA. Am J Epidemiol; 2012 Jun 01; 175(11):1120-8. PubMed ID: 22582207 [Abstract] [Full Text] [Related]
11. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vellozzi C, Broder KR, Haber P, Guh A, Nguyen M, Cano M, Lewis P, McNeil MM, Bryant M, Singleton J, Martin D, DeStefano F. Vaccine; 2010 Oct 21; 28(45):7248-55. PubMed ID: 20850534 [Abstract] [Full Text] [Related]
12. Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage --- United States, October-December 2009. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2010 Jan 22; 59(2):44-8. PubMed ID: 20094027 [Abstract] [Full Text] [Related]
14. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study. Juurlink DN, Stukel TA, Kwong J, Kopp A, McGeer A, Upshur RE, Manuel DG, Moineddin R, Wilson K. Arch Intern Med; 2006 Nov 13; 166(20):2217-21. PubMed ID: 17101939 [Abstract] [Full Text] [Related]
15. Guillain-Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990-2009). Souayah N, Yacoub HA, Khan HM, Farhad K, Mehyar LS, Maybodi L, Menkes DL, Qureshi AI. J Clin Neuromuscul Dis; 2012 Dec 13; 14(2):66-71. PubMed ID: 23172385 [Abstract] [Full Text] [Related]
16. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, Zuber P, Hua W, Bonhoeffer J, Buttery J, Crawford N, Deceuninck G, de Vries C, De Wals P, Gutierrez-Gimeno MV, Heijbel H, Hughes H, Hur K, Hviid A, Kelman J, Kilpi T, Chuang SK, Macartney K, Rett M, Lopez-Callada VR, Salmon D, Gimenez-Sanchez F, Sanz N, Silverman B, Storsaeter J, Thirugnanam U, van der Maas N, Yih K, Zhang T, Izurieta H, Global H1N1 GBS Consortium. Vaccine; 2013 Sep 13; 31(40):4448-58. PubMed ID: 23770307 [Abstract] [Full Text] [Related]
17. Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Wise ME, Viray M, Sejvar JJ, Lewis P, Baughman AL, Connor W, Danila R, Giambrone GP, Hale C, Hogan BC, Meek JI, Murphree R, Oh JY, Reingold A, Tellman N, Conner SM, Singleton JA, Lu PJ, DeStefano F, Fridkin SK, Vellozzi C, Morgan OW. Am J Epidemiol; 2012 Jun 01; 175(11):1110-9. PubMed ID: 22582209 [Abstract] [Full Text] [Related]
19. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010. Greene SK, Rett M, Weintraub ES, Li L, Yin R, Amato AA, Ho DT, Sheikh SI, Fireman BH, Daley MF, Belongia EA, Jacobsen SJ, Baxter R, Lieu TA, Kulldorff M, Vellozzi C, Lee GM. Am J Epidemiol; 2012 Jun 01; 175(11):1100-9. PubMed ID: 22582210 [Abstract] [Full Text] [Related]
20. Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverage - United States, October 2009-January 2010. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2010 Apr 02; 59(12):363-8. PubMed ID: 20360670 [Abstract] [Full Text] [Related] Page: [Next] [New Search]